APC and colorectal carcinoma: Similarly engineered CRC organoids with APC and KRAS mutations formed dysplasia and could invade submucosa (Takeda et al., 2019), and transformed mammary organoids formed tumors upon xenotransplantation (Dekkers et al., 2020).